ConductScience.org, home

Paper5769741

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.

Asbury AK and 2 others. Medicine (Baltimore), 1969. Cited by 735 papers, by iCite.

Cite this record

ConductScience Library. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Papers, record 5769741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5769741

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.
PubMed
Journal
Medicine (Baltimore)
PubMed
Year
1969
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
735
iCite
Revised in PubMed
2019-06-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Asbury AKA K
2Arnason BGB G
3Adams RDR D

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypersensitivity, DelayedMajor topic
Nerve DegenerationMajor topic
PolyradiculopathyMajor topic
Adult
Aged
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by150

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 735 citations.

PMIDTitleJournalYearIn PapersSource
42282969A recombinant IgG1 Fc-domain protein ameliorates inflammatory demyelinating peripheral neuropathy.Front Immunol2026https://conductscience.org/library/papers/42282969PubMed
41774118Sinomenine ameliorates experimental autoimmune neuritis by suppressing pro-inflammatory immune components and restoring immune balance.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41774118PubMed
40416578Tacrolimus associated Guillain-Barre syndrome.Arch Clin Cases2025https://conductscience.org/library/papers/40416578PubMed
40415889Endoneurial immune interplay in peripheral nerve repair: insights and implications for future therapeutic interventions.Front Neurosci2025https://conductscience.org/library/papers/40415889PubMed
40242772Case Report: Successful treatment of severe Guillain-Barré syndrome with paralytic ileus as a presenting symptom by intensive immunotherapy.Front Immunol2025https://conductscience.org/library/papers/40242772PubMed
40237241Brain-Derived Tau as an Outcome Marker in Guillain-Barré Syndrome: A Retrospective Cohort Study.Eur J Neurol2025https://conductscience.org/library/papers/40237241PubMed
38752584Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions.Eur J Neurol2024https://conductscience.org/library/papers/38752584PubMed
37891867Usefulness and Clinical Impact of Whole-Body MRI in Detecting Autoimmune Neuromuscular Disorders.Brain Sci2023https://conductscience.org/library/papers/37891867PubMed
37847215Granuloma, vasculitis, and demyelination in sarcoid neuropathy.Eur J Neurol2024https://conductscience.org/library/papers/37847215PubMed
37356965Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies.Brain Pathol2024https://conductscience.org/library/papers/37356965PubMed
37278272Progress in Guillain-Barré syndrome immunotherapy-A narrative review of new strategies in recent years.Hum Vaccin Immunother2023https://conductscience.org/library/papers/37278272PubMed
37139032Atypical Guillain-Barre Syndrome With a Sensory Level and Hyper-Acute Presentation: A Case Report.Cureus2023https://conductscience.org/library/papers/37139032PubMed
37108447Immune-Mediated Neuropathies: Pathophysiology and Management.Int J Mol Sci2023https://conductscience.org/library/papers/37108447PubMed
36569912Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis.Front Immunol2022https://conductscience.org/library/papers/36569912PubMed
36523267Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model.Brain Commun2022https://conductscience.org/library/papers/36523267PubMed
36133742Role of the Neutrophil to Lymphocyte Ratio in Guillain Barré Syndrome: A Systematic Review and Meta-Analysis.Mediators Inflamm2022https://conductscience.org/library/papers/36133742PubMed
36046684Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance.Oxid Med Cell Longev2022https://conductscience.org/library/papers/36046684PubMed
34549385Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.Neurotherapeutics2021https://conductscience.org/library/papers/34549385PubMed
33584245The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System.Front Aging Neurosci2020https://conductscience.org/library/papers/33584245PubMed
33359733New evidence for secondary axonal degeneration in demyelinating neuropathies.Neurosci Lett2021https://conductscience.org/library/papers/33359733PubMed

See all 150 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5769741

GET https://conductscience.org/api/papers/v1/5769741/cited_by?page=2